Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Investors Title (ITIC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Investors Title (ITIC) over the last 16 years, with Q3 2025 value amounting to $22.8 million.

  • Investors Title's Cash & Equivalents fell 1062.28% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year decrease of 1062.28%. This contributed to the annual value of $24.7 million for FY2024, which is 259.25% up from last year.
  • According to the latest figures from Q3 2025, Investors Title's Cash & Equivalents is $22.8 million, which was down 1062.28% from $29.7 million recorded in Q2 2025.
  • In the past 5 years, Investors Title's Cash & Equivalents ranged from a high of $48.5 million in Q3 2021 and a low of $584000.0 during Q4 2021
  • For the 5-year period, Investors Title's Cash & Equivalents averaged around $26.8 million, with its median value being $26.7 million (2024).
  • As far as peak fluctuations go, Investors Title's Cash & Equivalents plummeted by 8413.04% in 2021, and later soared by 59655.07% in 2023.
  • Over the past 5 years, Investors Title's Cash & Equivalents (Quarter) stood at $584000.0 in 2021, then surged by 490.75% to $3.4 million in 2022, then surged by 596.55% to $24.0 million in 2023, then increased by 2.59% to $24.7 million in 2024, then dropped by 7.69% to $22.8 million in 2025.
  • Its Cash & Equivalents stands at $22.8 million for Q3 2025, versus $29.7 million for Q2 2025 and $27.6 million for Q1 2025.